Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome

Peter J Schwartz, Silvia G Priori, Marina Cerrone, Carla Spazzolini, Attilio Odero, Carlo Napolitano, Raffaella Bloise, Gaetano M De Ferrari, Catherine Klersy, Arthur J Moss, Wojciech Zareba, Jennifer L Robinson, W Jackson Hall, Paul A Brink, Lauri Toivonen, Andrew E Epstein, Cuilan Li, Dayi Hu
2004-04-20
Abstract:Background— The management of long-QT syndrome (LQTS) patients who continue to have cardiac events (CEs) despite β-blockers is complex. We assessed the long-term efficacy of left cardiac sympathetic denervation (LCSD) in a group of high-risk patients. Methods and Results— We identified 147 LQTS patients who underwent LCSD. Their QT interval was very prolonged (QTc, 543±65 ms); 99% were symptomatic; 48% had a cardiac arrest; and 75% of those treated with β-blockers remained symptomatic. The average follow-up periods between first CE and LCSD and post-LCSD were 4.6 and 7.8 years, respectively. After LCSD, 46% remained asymptomatic. Syncope occurred in 31%, aborted cardiac arrest in 16%, and sudden death in 7%. The mean yearly number of CEs per patient dropped by 91% (P<0.001). Among 74 patients with only syncope before LCSD, all types of CEs decreased significantly as …
What problem does this paper attempt to address?